VAERS reports by lot

Moderna COVID-19 lot 02B21A: VAERS reports

33 VAERS reports list lot 02B21A as a Moderna COVID-19 vaccine, received between 2021-03-25 and 2023-09-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
9%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2027%
Cardiac / Cardiovascular1115%
Neurological1014%
Gastrointestinal811%
Injection-site / Local reaction68%
Musculoskeletal57%
Allergic / Anaphylactic45%
Dermatological (non-injection-site)45%
Respiratory34%
Autoimmune / Immune-mediated11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
Missouri3
Kentucky3
Washington2
Indiana2
Oklahoma2
Virginia2
Ohio2
Minnesota1
Nebraska1
South Carolina1
New York1

Reports by month received

2021-032
2021-047
2021-051
2021-062
2021-071
2021-089
2021-092
2021-101
2021-114
2022-011
2022-021
2022-031
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.